RecallFDA · Jul 16, 2020
Named company: Provident Nutraceutical div. of Ortho Molecular Products Inc
Various branded dietary supplements may contain undeclared soy.
Import alertFDA · Jul 16, 2020
Named company: Bjp Laboratories Pty Ltd
DETENTION WITHOUT PHYSICAL EXAMINATION OF DIETARY SUPPLEMENT PRODUCTS FROM FIRMS THAT HAVE NOT MET DIETARY SUPPLEMENT GMP. Firm/address: Bjp Laboratories Pty Ltd Date Published : 07/16/2020 2/38 Computer…
RecallFDA · Jul 13, 2020
Named company: Lopez Gonzalez Santana Corporation
CGMP Deviations: Presence of damaged tablets
RecallFDA · Jul 13, 2020
Named company: Lopez Gonzalez Santana Corporation
CGMP Deviations: Presence of damaged tablets
Warning letterFDA · Jul 13, 2020
Named company: Kegan Wellness
Based on our review, these products are unapproved new drugs sold in violation of section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. § 355(a). Furthermore, these products are…
Warning letterFDA · Jul 10, 2020
Named company: Health Beauty Love
Based on our review, this product is an unapproved new drug sold in violation of section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. § 355(a). Furthermore, this product is a…
Warning letterFDA · Jul 6, 2020
Named company: Lotus Herbal Supplements
Based on our review, this product is an unapproved new drug sold in violation of section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. § 355(a). Furthermore, this product is a…
Warning letterFDA · Jun 30, 2020
Named company: Center for Wellness and Integrative Medicine
Based on our review, these products are unapproved new drugs sold in violation of section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. § 355(a). Furthermore, these products are…
Warning letterFDA · Jun 26, 2020
Named company: SuperHealthGuard and Loyal Great International Ltd.
Based on our review, this product is an unapproved new drug sold in violation of section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. § 355(a). Furthermore, this product is a…
Warning letterFDA · Jun 18, 2020
Named company: Project 1600 Inc.
Based on our review, these products are unapproved new drugs sold in violation of section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. § 355(a). Furthermore, these products are…